Fig. 2

GEPIA database and tissue slice detection of DNMT1, SOS1, and miR-152-3p expression in NSCLCs A DNMT1 expression at each stage of LUSC; B DNMT1 expression at each metastatic stage of LUSC; C DNMT1 expression at each stage of LUAD; D DNMT1 expression at each metastatic stage of LUAD; E SOS1 expression in each metastatic stage of LUSC; F Expression levels of SOS1 in each metastatic stage of LUSC; G Correlation of DNMT1 and SOS1 expression in LUSC; H Association of DNMT1 and SOS1 expression in LUAD; I DNMT1, SOS1, and miR-152-3p low-expression representative images; J DNMT1, SOS1, and miR-152-3p high-expression representative images; K Percentage of high and low DNMT1, SOS1, and miR-152-3p expression in 25 NSCLC tumor sections; LThe percentage of DNMT1 high-expression, and (or) SOS1 high-expression and (or) miR-152-3p low-expression in 25 non-small cell tumor sections.*p < 0.05; **p < 0.01; ***p < 0.001